Steven Elliott

3.8k citations

66 papers · 3.0k indexed · h-index 31

Impact in

Hematology top 2%
- Erythropoietin and Anemia Treatment
Cancer Research top 5%
- MicroRNA in disease regulation

Papers in

Biochemistry 5
Hematology 9
- Erythropoietin and Anemia Treatment 9

Co-authors: Matthew E. Burow Barbara S. Beckman John A. McLachlan Lyndsay V. Rhodes James W. Antoon Bridgette M. Collins‐Burow Stephen M. Boué Thomas Wiese
Journals: PLoS ONE (4 papers)Cancer Research (3 papers)Breast Cancer Research and Treatment (3 papers)Blood (3 papers)Journal of Agricultural and Food Chemistry (2 papers)
Partner nations: United States Czechia United Kingdom

In The Last Decade

Steven Elliott

64 papers receiving 2.9k citations

Peers

Countries citing papers authored by Steven Elliott

Since Specialization

Citations

This map shows the geographic impact of Steven Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Elliott more than expected).

Fields of papers citing papers by Steven Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Elliott. The network helps show where Steven Elliott may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Elliott Line = papers co-authored together Steven Elliott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer Frontiers in Molecular Biosciences ·Wen-Bin Wu, Margarite D. Matossian, Magnus Norberg, Khoa Nguyen, John Fontanese, Celia Byrne, Steven Elliott, Hope E. Burks, Melyssa R. Bratton, Nicholas C. Pashos, Bruce A. Bunnell, Matthew E. Burow, Bridgette M. Collins‐Burow, Elizabeth C. Martin	2022	5
2	Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor PLoS ONE ·U W Dreessen, Margarite D. Matossian, Steven Elliott, Hope E. Burks, Rachel A. Sabol, Deniz A. Uçar, „Nachhaltigen Konsum weiterdenken“ Projekt-Team, Jovanny Zabaleta, Luis Del Valle, Yasuhiko KIKKAWA, Elizabeth C. Martin, Adam I. Riker, Lucio Miele, Bruce A. Bunnell, Matthew E. Burow, Bridgette M. Collins‐Burow	2020	13
3	Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer Women s Health Reports ·Margarite D. Matossian, Orozco Vidal, John Fontanese, Steven Elliott, Maria V. Yershova, Khoa Nguyen, Arnold H. Zea, Frank H. Lau, Krzysztof Moroz, Adam I. Riker, Steven D. Jones, Elizabeth C. Martin, Bruce A. Bunnell, Lucio Miele, Bridgette M. Collins‐Burow, Matthew E. Burow	2020	6
4	Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model BMC Cancer ·Margarite D. Matossian, Hope E. Burks, Steven Elliott, Van T. Hoang, Annie C. Bowles, Rachel A. Sabol, A.A.A. Sharaf El-Den, Muralidharan Anbalagan, Brian G. Rowan, Mohamed E. Abazeed, Bruce A. Bunnell, Krzysztof Moroz, Lucio Miele, Lyndsay V. Rhodes, Steven D. Jones, Elizabeth C. Martin, Bridgette M. Collins‐Burow, Matthew E. Burow	2019	22
5	Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes PLoS ONE ·Margarite D. Matossian, Steven Elliott, Van T. Hoang, Hope E. Burks, Theresa B. Phamduy, Douglas B. Chrisey, William J. Zuercher, David H. Drewry, Carrow I. Wells, Bridgette M. Collins‐Burow, Matthew E. Burow	2017	4
6	Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators Breast Cancer Research and Treatment ·Lyndsay V. Rhodes, Chandra R. Tate, H. Chris Segar, Hope E. Burks, Theresa B. Phamduy, Van T. Hoang, Steven Elliott, Schwartz H. G, F. Nell Pounder, Muralidharan Anbalagan, Douglas B. Chrisey, Brian G. Rowan, Matthew E. Burow, Bridgette M. Collins‐Burow	2014	81
7	Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms Stem Cell Research & Therapy ·Amy L. Strong, Jason F. Ohlstein, Quan Jiang, Qiang Zhang, Shilong Zheng, Stephen M. Boué, Steven Elliott, Jeffrey M. Gimble, Matthew E. Burow, Guangdi Wang, Bruce A. Bunnell	2014	29
8	Chemotherapy-induced anemia: the story of darbepoetin alfa Current Medical Research and Opinion ·Johan Vansteenkiste, Yannick Fischer, Steven Elliott, John A. Glaspy, Michael Hedenus	2013	7
9	Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition International Journal of Oncology ·James W. Antoon, 吴小巧, Elizabeth C. Martin, Lyndsay V. Rhodes, Seungyoon Nam, Scott Wadsworth, Katherine E. Stannard, Steven Elliott, Bridgette M. Collins‐Burow, Kenneth P. Nephew, Matthew E. Burow	2013	29
10	Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration Breast Cancer Research ·Changhua Zhou, Qiu Zhong, Lyndsay V. Rhodes, Ian K. Townley, Melyssa R. Bratton, Qiang Zhang, Elizabeth C. Martin, Steven Elliott, Bridgette M. Collins‐Burow, Matthew E. Burow, Guangdi Wang	2012	96
11	Gαo potentiates estrogen receptor α activity via the ERK signaling pathway Journal of Endocrinology ·Melyssa R. Bratton, James W. Antoon, А. Б. Джураев, Daniel E. Frigo, Syreeta L. Tilghman, Bridgette M. Collins‐Burow, Steven Elliott, Yan Tang, Lilia I. Melnik, Ling Lai, Jawed Alam, Barbara S. Beckman, Steven M. Hill, Brian G. Rowan, John A. McLachlan, Matthew E. Burow	2012	17
12	Effects of SDF-1–CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells Experimental Cell Research ·Lyndsay V. Rhodes, Melyssa R. Bratton, Yun Zhu, Syreeta L. Tilghman, Shannon E. Muir, Virgilio A. Salvo, Chandra R. Tate, Steven Elliott, Kenneth P. Nephew, Bridgette M. Collins‐Burow, Matthew E. Burow	2011	30
13	Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2 Cancer Biology & Therapy ·James W. Antoon, Kinjal K Purohit, Gan Zi-y, Jennifer Driver, 云燕, Steven Elliott, Charles D. Smith, Matthew E. Burow, Barbara S. Beckman	2011	126
14	Erythropoietins, Erythropoietic Factors, and Erythropoiesis Birkhäuser Basel eBooks ·Steven Elliott, Hermala Hermala, Graham Molineux	2009	27
15	Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence Breast Cancer Research and Treatment ·Lyndsay V. Rhodes, Shannon E. Muir, Steven Elliott, W. L. Chen, James W. Antoon, Patrice Penfornis, Syreeta L. Tilghman, Virgilio A. Salvo, Juan P. Fonseca, Michelle Lacey, Barbara S. Beckman, John A. McLachlan, Brian G. Rowan, Radhika Pochampally, Matthew E. Burow	2009	91
16	Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype Breast Cancer Research ·Changhua Zhou, Rosaria Oktafiani Darmawan, R. Berdymuradov, Qiang Zhang, Yan Tang, Michael J. Bloch, Steven Elliott, Yun Zhu, Lindsey E. Bazzone, David C. Yu, Christopher B. Weldon, Rachel Schiff, John A. McLachlan, Barbara S. Beckman, Thomas Wiese, Kenneth P. Nephew, Bin Shan, Matthew E. Burow, Guangdi Wang	2008	91
17	Evaluation of hyperglycosylated erythropoiesis stimulating proteins developed using glycoengineering Cancer Research ·Steven Elliott, Kenneth H. Aoki, Balaji Agoram, David Brankow, Sameer Doshi, Graham Molineux	2006	1
18	p38 Mitogen-Activated Protein Kinase Stimulates Estrogen-Mediated Transcription and Proliferation through the Phosphorylation and Potentiation of the p160 Coactivator Glucocorticoid Receptor-Interacting Protein 1 Molecular Endocrinology ·Daniel E. Frigo, Aninda Basu, علی اصغر بیانی, Christopher B. Weldon, N. Manwani, Steven Elliott, Bridgette M. Collins‐Burow, Virgilio A. Salvo, Yun Zhu, Lilia I. Melnik, Gabriela N. Lopez, Peter J. Kushner, Tyler J. Curiel, Brian G. Rowan, John A. McLachlan, Matthew E. Burow	2006	46
19	Characterization of two fluorescent tryptophans in recombinant human granulocyte-colony stimulating factor: Comparison of native sequence protein and tryptophan-deficient mutants Journal of Protein Chemistry ·Carl G. Kolvenbach, Steven Elliott, Raj Sachdev, Tsutomu Arakawa, Linda O. Narhi	1993	17
20	The Yeast Cell Cycle: Coordination of Growth and Division Rates Progress in nucleic acid research and molecular biology ·Steven Elliott	1983	18

About Steven Elliott

Steven Elliott is a scholar working on Biochemistry, Hematology, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 66 papers that have together received 3.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (12 papers), Cancer Cells and Metastasis (9 papers), Erythropoietin and Anemia Treatment (9 papers), Cytokine Signaling Pathways and Interactions (9 papers), Phytoestrogen effects and research (8 papers), Melanoma and MAPK Pathways (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Hematology (409 citations), Cancer Research (427 citations), Biochemistry (166 citations), Oncology (690 citations) and Molecular Biology (1.6k citations). Steven Elliott has collaborated with scholars based in United States, Czechia and United Kingdom. Frequent co-authors include Matthew E. Burow, Barbara S. Beckman, John A. McLachlan, Lyndsay V. Rhodes, James W. Antoon, Bridgette M. Collins‐Burow, Stephen M. Boué, Thomas Wiese, Thomas E. Cleveland and Carol H. Carter‐Wientjes. Their work appears in journals such as PLoS ONE, Cancer Research, Breast Cancer Research and Treatment, Blood and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact